BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34617981)

  • 1. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
    Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
    JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes.
    Hebert R; Cullinan N; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Coltin H; Deyell RJ; Felton K; Fernandez CV; Fleming AJ; Gibson P; Hammad R; Jabado N; Johnston DL; Lafay-Cousin L; Larouche V; Leblanc-Desrochers C; Michaeli O; Perrier R; Pike M; Say J; Schiller I; Toupin AK; Vairy S; van Engelen K; Waespe N; Villani A; Foulkes WD; Malkin D; Reichman L; Goudie C
    J Med Genet; 2023 Nov; 60(12):1218-1223. PubMed ID: 37460202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes.
    Byrjalsen A; Hansen TVO; Stoltze UK; Mehrjouy MM; Barnkob NM; Hjalgrim LL; Mathiasen R; Lautrup CK; Gregersen PA; Hasle H; Wehner PS; Tuckuviene R; Sackett PW; Laspiur AO; Rossing M; Marvig RL; Tommerup N; Olsen TE; Scheie D; Gupta R; Gerdes AM; Schmiegelow K; Wadt K
    PLoS Genet; 2020 Dec; 16(12):e1009231. PubMed ID: 33332384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors.
    Goudie C; Cullinan N; Villani A; Mathews N; van Engelen K; Malkin D; Irwin MS; Foulkes WD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27390. PubMed ID: 30117275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of the McGill interactive pediatric oncogenetic guidelines in identifying Li-Fraumeni syndrome in female patients with osteosarcoma.
    Rios JD; Simbulan F; Reichman L; Caswell K; Tachdjian M; Malkin D; Cotton C; Nathan PC; Goudie C; Pechlivanoglou P
    Pediatr Blood Cancer; 2024 May; ():e31077. PubMed ID: 38783403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
    Cullinan N; Schiller I; Di Giuseppe G; Mamun M; Reichman L; Cacciotti C; Wheaton L; Caswell K; Di Monte B; Gibson P; Johnston DL; Fleming A; Pole JD; Malkin D; Foulkes WD; Dendukuri N; Goudie C; Nathan PC
    J Clin Oncol; 2021 Oct; 39(29):3207-3216. PubMed ID: 34383599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An eHealth decision-support tool to prioritize referral practices for genetic evaluation of patients with Wilms tumor.
    Cullinan N; Villani A; Mourad S; Somers GR; Reichman L; van Engelen K; Stephens D; Weksberg R; Foulkes WD; Malkin D; Grant R; Goudie C
    Int J Cancer; 2020 Feb; 146(4):1010-1017. PubMed ID: 31286500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation.
    Goudie C; Coltin H; Witkowski L; Mourad S; Malkin D; Foulkes WD
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.
    Lincoln SE; Nussbaum RL; Kurian AW; Nielsen SM; Das K; Michalski S; Yang S; Ngo N; Blanco A; Esplin ED
    JAMA Netw Open; 2020 Oct; 3(10):e2019452. PubMed ID: 33026450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm.
    Bakhuizen JJ; Hopman SMJ; Bosscha MI; Dommering CJ; van den Heuvel-Eibrink MM; Hol JA; Kester LA; Koudijs MJ; Langenberg KPS; Loeffen JLC; van der Lugt J; Moll AC; van Noesel MM; Smetsers SE; de Vos-Kerkhof E; Merks JHM; Kuiper RP; Jongmans MCJ
    JAMA Netw Open; 2023 Feb; 6(2):e2254157. PubMed ID: 36735256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.
    Brozou T; Taeubner J; Velleuer E; Dugas M; Wieczorek D; Borkhardt A; Kuhlen M
    Eur J Pediatr; 2018 Jan; 177(1):53-60. PubMed ID: 28929227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
    Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
    JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood Cancer Predisposition: An Overview for the General Pediatrician.
    Kagami L; Baldino S; MacFarland SP
    Pediatr Ann; 2022 Jan; 51(1):e15-e21. PubMed ID: 35020509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Factors Associated With the Evaluation of Children for Leukemia Predisposition Syndromes: A Retrospective Single-center Study.
    D'Aquila KR; Kessler E; Cooper KL; Durst A; Meade J
    J Pediatr Hematol Oncol; 2023 Jul; 45(5):e597-e602. PubMed ID: 37027191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States.
    Venier RE; Grubs RE; Kessler E; Cooper KL; Bailey KM; Meade J
    J Genet Couns; 2022 Aug; 31(4):901-911. PubMed ID: 35147246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children's hospital.
    Huber S; Schimmel M; Dunstheimer D; Nemes K; Richter M; Streble J; Vollert K; Walden U; Frühwald MC; Kuhlen M
    Eur J Pediatr; 2022 Apr; 181(4):1585-1596. PubMed ID: 34950979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee.
    Grant CN; Rhee D; Tracy ET; Aldrink JH; Baertschiger RM; Lautz TB; Glick RD; Rodeberg DA; Ehrlich PF; Christison-Lagay E
    J Pediatr Surg; 2022 Mar; 57(3):430-442. PubMed ID: 34503817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children.
    Friedrich UA; Bienias M; Zinke C; Prazenicova M; Lohse J; Jahn A; Menzel M; Langanke J; Walter C; Wagener R; Brozou T; Varghese J; Dugas M; Erlacher M; Schröck E; Suttorp M; Borkhardt A; Hauer J; Auer F
    Genet Med; 2023 Aug; 25(8):100875. PubMed ID: 37149759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
    Horton C; Hoang L; Zimmermann H; Young C; Grzybowski J; Durda K; Vuong H; Burks D; Cass A; LaDuca H; Richardson ME; Harrison S; Chao EC; Karam R
    JAMA Oncol; 2024 Feb; 10(2):212-219. PubMed ID: 37924330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective identification of cancer predisposition syndromes in children with cancer employing a questionnaire.
    Schwermer M; Behnert A; Dörgeloh B; Ripperger T; Kratz CP
    Fam Cancer; 2021 Oct; 20(4):257-262. PubMed ID: 33651299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.